Director, Scientific Publications
AstraZeneca
Summary
The Director, Scientific Publications is responsible for the development of high-quality clinical publications and reviews for investigational pipeline products in Oncology R&D. In addition, the Director will be responsible for the development and delivery of strategic Publication Plans for pipeline assets. The Director will also have the opportunity to lead cross-functional publication teams, ensure publication plans align with project and overall Oncology R&D strategy, and ensure that these partnerships are successful and that plans represent a transparent and fair balanced communication of data.
Job description
Accountabilities
- Leads the cross-functional team responsible for the publication development process to deliver high-quality publication.
- Effectively collaborates with key partners and ensures compliance with internal and external publication guidelines.
- Leads the cross-functional team to deliver strategic publications plans that are aligned with project strategy.
- Accountable for managing 3rd-party providers in the delivery of defined publications activity, ensuring quality and delivery standards are adhered to.
- Develops and ensures that strategically aligned scientific communication points are delivered and that statements and conclusions in publications are accurate and supported by appropriate data.
- Uses subject matter expertise to provide publications insight to partners, collaborators, and more junior team members.
- Provides on-site support at key scientific congresses and meetings.
- Ensures the high quality and transparency of publications by maintaining/promoting familiarity with ICMJE, GPP3, CONSORT, AMA, and other external standards as well as AstraZeneca publication policies and procedures.
Essential Skills/Experience
- PhD, PharmD, MD or advanced scientific degree in a biomedical field with proven scientific and/or publications expertise
- 5+ years of experience in medical communications/publications in pharmaceutical/biotech industry, medical communications agency, CRO, publishing, or academic setting with equivalent work experience required
- Proven track record of collaborative and consultative cross-matrix abilities
- The ability to appreciate and work within a large strategic framework, while maintaining strong attention to detail and compliance to global publications ethical standards and company publications policy and SOPs
- Ability to understand and adhere to good publication practices and relevant guidelines on and scientific data communication, such as ICMJE, GPP3, company policy and SOPs
- Detailed working knowledge and understanding of publication strategy and planning
- Previous experience with management of contract resources/vendors
- Demonstrated ability and flexibility to prioritize while supporting multiple projects, dealing effectively with change and ambiguity
- Broad understanding of drug development process
- Demonstrated ability to establish and maintain professional relationships with external experts, investigators, journal editors and publishers and professional bodies
- Working knowledge of Datavision publication management systems
- Demonstrated ability to mentor others during the flow of work
- Proficiency in Microsoft Office applications (Word, Excel, Powerpoint) required
- Solid understanding of publication management databases (iEnvision, Datavision)
Preferred Skills/Experience
- AMWA, BELS, and/or ISMPP (CMPP) certification
- Background in biologics and/or previous experience in oncology products
- Previous experience writing and editing peer-reviewed clinical publications highly desirable
Requirements
- PhD, PharmD, MD or advanced scientific degree in a biomedical field with proven scientific and/or publications expertise
- 5+ years of experience in medical communications/publications in pharmaceutical/biotech industry, medical communications agency, CRO, publishing, or academic setting with equivalent work experience required
- Proven track record of collaborative and consultative cross-matrix abilities
- The ability to appreciate and work within a large strategic framework, while maintaining strong attention to detail and compliance to global publications ethical standards and company publications policy and SOPs
- Ability to understand and adhere to good publication practices and relevant guidelines on and scientific data communication, such as ICMJE, GPP3, company policy and SOPs
- Detailed working knowledge and understanding of publication strategy and planning
- Previous experience with management of contract resources/vendors
- Demonstrated ability and flexibility to prioritize while supporting multiple projects, dealing effectively with change and ambiguity
- Broad understanding of drug development process
- Demonstrated ability to establish and maintain professional relationships with external experts, investigators, journal editors and publishers and professional bodies
- Working knowledge of Datavision publication management systems
- Demonstrated ability to mentor others during the flow of work
- Proficiency in Microsoft Office applications (Word, Excel, Powerpoint) required
- Solid understanding of publication management databases (iEnvision, Datavision)
- AMWA, BELS, and/or ISMPP (CMPP) certification
- Background in biologics and/or previous experience in oncology products
- Previous experience writing and editing peer-reviewed clinical publications highly desirable
Benefits
- Health insurance
- Dental coverage
- Vision coverage
- Retirement programs
- Paid time off
- Short-term incentive bonuses
- Equity-based awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.